Globally licensed cannabis company ABcann Global Corp.
(TSX.V: ABCN) (OTCQB: ABCCF), through wholly owned subsidiary Harvest Medicine
Inc., this morning announced that it has surpassed 15,000 active patients in
under 18 months of operation. “Our rapid growth is a testament to our
patient-centric approach and dedication to providing exceptional care,” Shekhar
Parmar, CEO of Harvest Medicine, stated in the news release. “We partner with
patients to empower them to be more involved in their healthcare and ensure
that they receive the safest and most effective medical cannabis treatment for
their individualized needs.” Per the update, Harvest Medicine, one of Canada’s
fastest growing specialty medical cannabis clinics, is poised to take its
education-focused model across Canada through the opening of new locations and
the anticipated late-summer launch of a purpose-build telemedicine app.
Notably, the company intends to open a new location in the Edmonton area in
July of this year.
To view the full press release, visit http://ibn.fm/EkyVo
About ABcann Global Corp.
ABcann is recognized for high-quality, trusted products and
services. It holds production and sales licenses from Health Canada, and its
flagship facility in Napanee, Ontario contains proprietary plant-growing
technology, centered on its specially designed, environmentally-controlled
growing chambers. This approach results in the production of
pharmaceutical-grade cannabis products. ABcann is expanding its production
capacity and pursuing partnership and product development opportunities
domestically, as well as in select international markets, such as Germany,
Australia and Israel. For more information, visit the company’s website
at www.ABcannGlobal.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
